LeonaBio Inc/$LONA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About LeonaBio Inc
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
Ticker
$LONA
Sector
Primary listing
Employees
19
Headquarters
Website
LeonaBio Inc Metrics
BasicAdvanced
$82m
-
-$24.70
2.23
-
Price and volume
Market cap
$82m
Beta
2.23
52-week high
$14.21
52-week low
$3.60
Average daily volume
75k
Financial strength
Current ratio
1.883
Quick ratio
1.411
Long term debt to equity
1.216
Total debt to equity
6.268
Profitability
EBITDA (TTM)
-101.294
Management effectiveness
Return on assets (TTM)
-28.31%
Return on equity (TTM)
-290.81%
Valuation
Price to book
1.67
Price to tangible book (TTM)
1.67
Price to free cash flow (TTM)
-0.813
Free cash flow yield (TTM)
-123.07%
Free cash flow per share (TTM)
-10.695
Growth
Earnings per share change (TTM)
-1.96%
3-year earnings per share growth (CAGR)
-0.86%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for LeonaBio Inc stock?
LeonaBio Inc (LONA) has a market cap of $82M as of April 29, 2026.
What is the P/E ratio for LeonaBio Inc stock?
The price to earnings (P/E) ratio for LeonaBio Inc (LONA) stock is 0 as of April 29, 2026.
Does LeonaBio Inc stock pay dividends?
No, LeonaBio Inc (LONA) stock does not pay dividends to its shareholders as of April 29, 2026.
When is the next LeonaBio Inc dividend payment date?
LeonaBio Inc (LONA) stock does not pay dividends to its shareholders.
What is the beta indicator for LeonaBio Inc?
LeonaBio Inc (LONA) has a beta rating of 2.23. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.